Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Malignant Tumours”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00516438
What this trial is testing

Study to Assess the Safety and Tolerability of a PARP Inhibitor in Combination With Topotecan

Who this might be right for
Malignant Solid Tumors
AstraZeneca 48
Testing effectiveness (Phase 2)Active Not RecruitingNCT02978625
What this trial is testing

Talimogene Laherparepvec and Nivolumab in Treating Patients With Refractory Lymphomas or Advanced or Refractory Non-melanoma Skin Cancers

Who this might be right for
Anaplastic Large Cell Lymphoma, ALK-NegativeAnaplastic Large Cell Lymphoma, ALK-PositiveApocrine Carcinoma+36 more
National Cancer Institute (NCI) 68
Testing effectiveness (Phase 2)Active Not RecruitingNCT05715281
What this trial is testing

Testing the Combination of Anti-cancer Drugs Atezolizumab and Tiragolumab in People With Advanced Stage Rare Cancers, RARE3 Trial

Who this might be right for
Advanced Rare Malignant Solid NeoplasmRare Malignant Solid NeoplasmRefractory Rare Malignant Solid Neoplasm
National Cancer Institute (NCI) 12
Early research (Phase 1)Ended earlyNCT00801151
What this trial is testing

Vorinostat in Combination With Vinorelbine in Patients With Advanced Cancer

Who this might be right for
Malignant Solid Tumour
Institut Claudius Regaud 30
Early research (Phase 1)Study completedNCT01023737
What this trial is testing

Hydroxychloroquine + Vorinostat in Advanced Solid Tumors

Who this might be right for
Malignant Solid Tumour
The University of Texas Health Science Center at San Antonio 72
Large-scale testing (Phase 3)Study completedNCT02591030
What this trial is testing

Safety and Efficacy of Modified Folfirinox Versus Gemcis in Bile Duct Tumours

Who this might be right for
Bile Duct Cancer
Centre Hospitalier Universitaire de Saint Etienne 191
Early research (Phase 1)Study completedNCT00516802
What this trial is testing

Assess the Safety and Pharmacokinetics of an Inhibitor of PARP in Combination With Dacarbazine

Who this might be right for
Melanoma Neoplasms
AstraZeneca 40
Early research (Phase 1)Study completedNCT01022853
What this trial is testing

Combination of BI6727 (Volasertib) and BIBF1120 in Solid Tumors

Who this might be right for
Neoplasms
Boehringer Ingelheim 30
Not applicableStudy completedNCT02604472
What this trial is testing

Retrospective Investigation of the Impacts of Prognosis for Nasopharyngeal Carcinoma Patients

Who this might be right for
Malignant Neoplasm of Other Specified Site of Nasopharynx
Sun Yat-sen University 12,206
Not applicableUnknownNCT06031636
What this trial is testing

Oncolytic Adenovirus(H101) Combined With PD-1 Inhibitors in Patients With Advanced Malignant Pleural Mesothelioma

Who this might be right for
Malignant Pleural Mesothelioma, Advanced
Tianjin Medical University Second Hospital 15
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06297811
What this trial is testing

Myeloprotection With Trilaciclib in Pan-cancer Population

Who this might be right for
Non-Small Cell Lung CancerBreast CancerEndometrial Cancer+2 more
Sun Yat-sen University 132
Early research (Phase 1)Study completedNCT02482311
What this trial is testing

Safety, Tolerance, PK, and Anti-tumour Activity of AZD1775 Monotherapy in Patients With Advanced Solid Tumours

Who this might be right for
Ovarian Cancer, TNBC, SCLC, Other Solid Tumours
AstraZeneca 92
Early research (Phase 1)Study completedNCT00783328
What this trial is testing

PF-00299804 In Patients In Japan With Advanced Malignant Solid Tumors

Who this might be right for
Neoplasms
Pfizer 13
Large-scale testing (Phase 3)Study completedNCT02784171
What this trial is testing

Pembrolizumab in Patients With Advanced Malignant Pleural Mesothelioma

Who this might be right for
Mesothelioma
Canadian Cancer Trials Group 520
Early research (Phase 1)Active Not RecruitingNCT02389309
What this trial is testing

Dasatinib, Temsirolimus, and Cyclophosphamide in Treating Patients With Advanced, Recurrent, or Refractory Solid Tumors

Who this might be right for
Advanced Malignant Solid NeoplasmRecurrent Brain NeoplasmRecurrent Malignant Solid Neoplasm+1 more
M.D. Anderson Cancer Center 14
Not applicableStudy completedNCT04889144
What this trial is testing

PLAN Intervention to Enhance Engagement of Latino Cancer Patients in Advanced Care Planning

Who this might be right for
Locally Advanced Malignant Solid NeoplasmMetastatic Malignant Solid Neoplasm
Fred Hutchinson Cancer Center 27
Early research (Phase 1)Study completedNCT05082545
What this trial is testing

Phase I Study of SHR-2002 + SHR-1316 in Patients With Advanced Malignant Tumors

Who this might be right for
Advanced Malignant Tumors
Atridia Pty Ltd. 19
Early research (Phase 1)Study completedNCT01639911
What this trial is testing

Phase I Study of MLN8237 and Pazopanib in Patients With Solid Tumors

Who this might be right for
Malignant Neoplasm of BreastCNS MalignancyMalignant Neoplasm of Gastrointestinal Tract+4 more
University of Illinois at Chicago 28
Not applicableStudy completedNCT03168763
What this trial is testing

Effect of Physician Attire on Patients' Preference of Physician

Who this might be right for
Malignant Neoplasms of Independent (Primary) Multiple Sites
M.D. Anderson Cancer Center 108
Testing effectiveness (Phase 2)UnknownNCT03139487
What this trial is testing

Phase II Open Label Study to Compare the Safety and Efficacy of Subcutaneous Dalteparin Versus Direct Oral Anticoagulants for Cancer-associated Venous Thromboembolism

Who this might be right for
Cancer-associated ThrombosisEsophageal CancerStomach Cancer+7 more
Asan Medical Center 176
Next Page